Book contents
- The Cambridge Handbook of Substance and Behavioral Addictions
- The Cambridge Handbook of Substance and Behavioral Addictions
- Copyright page
- Contents
- Figures
- Tables
- Contributors
- Foreword
- Preface
- Acknowledgements
- Part I Concepts of Addiction
- Part II Clinical and Research Methods in the Addictions
- Part III Levels of Analysis and Etiology
- Part IV Prevention and Treatment
- Part V Ongoing and Future Research Directions
- 24 Precision Behavioral Management (PBM): A Novel Genetically Guided Therapy to Combat Reward Deficiency Syndrome (RDS) Relevant to the Opiate Crisis
- 25 Novel Psychoactive Substances: A New Challenge for Prevention and Treatment
- 26 Impaired Physicians
- 27 Feedback Models for Gambling Control: The Use and Efficacy of Online Responsible Gambling Tools
- 28 Food versus Eating Addictions
- 29 Measurement, Prevention, and Treatment of Exercise Addiction
- 30 Tanning as an Addiction: The State of the Research and Implications for Intervention
- 31 Considering the Overlap and Nonoverlap of Compulsivity, Impulsivity, and Addiction
- 32 Anhedonia in Addictive Behaviors
- 33 Mindfulness-Based Interventions Applied to Addiction Treatments
- 34 American Legal Issues in Addiction Treatment and Research
- Index
- References
34 - American Legal Issues in Addiction Treatment and Research
from Part V - Ongoing and Future Research Directions
Published online by Cambridge University Press: 13 July 2020
Edited by
Book contents
- The Cambridge Handbook of Substance and Behavioral Addictions
- The Cambridge Handbook of Substance and Behavioral Addictions
- Copyright page
- Contents
- Figures
- Tables
- Contributors
- Foreword
- Preface
- Acknowledgements
- Part I Concepts of Addiction
- Part II Clinical and Research Methods in the Addictions
- Part III Levels of Analysis and Etiology
- Part IV Prevention and Treatment
- Part V Ongoing and Future Research Directions
- 24 Precision Behavioral Management (PBM): A Novel Genetically Guided Therapy to Combat Reward Deficiency Syndrome (RDS) Relevant to the Opiate Crisis
- 25 Novel Psychoactive Substances: A New Challenge for Prevention and Treatment
- 26 Impaired Physicians
- 27 Feedback Models for Gambling Control: The Use and Efficacy of Online Responsible Gambling Tools
- 28 Food versus Eating Addictions
- 29 Measurement, Prevention, and Treatment of Exercise Addiction
- 30 Tanning as an Addiction: The State of the Research and Implications for Intervention
- 31 Considering the Overlap and Nonoverlap of Compulsivity, Impulsivity, and Addiction
- 32 Anhedonia in Addictive Behaviors
- 33 Mindfulness-Based Interventions Applied to Addiction Treatments
- 34 American Legal Issues in Addiction Treatment and Research
- Index
- References
Summary
This chapter discusses the relevance of addiction to the law in the United States. Current law pertains almost solely to substance addictions, as there is no legal status pertaining to most behavioral addictions. Particular emphasis is placed on the law’s impact on the provision of care and research of addiction. The conflicting legal concerns for confidentiality of treatment and research, on the one hand, and apprehension of addicts who break the law, on the other hand, are examined.
Keywords
- Type
- Chapter
- Information
- The Cambridge Handbook of Substance and Behavioral Addictions , pp. 418 - 425Publisher: Cambridge University PressPrint publication year: 2020
References
American Psychiatric Association (2013). Diagnostic and Statistical Manual of Mental Disorders (5th edition). Arlington: American Psychiatric Association.Google Scholar
American Psychiatric Association (2018). Position Statement on Inquiries about Diagnosis and Treatment of Mental Disorders in Connection with Professional Credentialing and Licensing.Google Scholar
Americans with Disabilities Act, 42 U.S.C. sections 12101, et seq., 12102(1)(A), 12114, 12210, 12211, 12214.Google Scholar
Azim, A. (2018). Note: Common sense; Rethinking the new Common Rule’s weak protections for human subjects. Vanderbilt Law Review, 71, 1704–1736.Google Scholar
Belmont Report (1979). National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research. The Belmont Report: Ethical Principles and Guidelines for the Protection of Human Subjects of Research. www.hhs.gov/ohrp/sites/default/files/the-belmont-report-508c_Final.pdf.Google Scholar
Bollas, C. & Sundelson, D. (1995) The New Informants: The Betrayal of Confidentiality in Psychoanalysis and Psychotherapy. Northvale, N.J.: Jason Aronson, Inc.Google Scholar
California Business and Professions Code sections 740-742, 2241.5.Google Scholar
California Civil Code sections 43.92, 51, 51.5, 56.10(c)(19), 56.104, 56.35.Google Scholar
California Confidentiality of Medical Information Act, Civil Code sections 56.10(c)(19), 56.104, 56.35.Google Scholar
California Constitution, Article I, sections 1 and 13.Google Scholar
California Evidence Code sections 990-1007. Physician-patient privilege.Google Scholar
California Evidence Code sections 995, 1015.Google Scholar
California Evidence Code sections 1010-1027. Psychotherapist-patient privilege.Google Scholar
California Health and Safety Code sections 11165.4, 11480-11481, 11812, 11845.5, 24170-24179.5, 111515-111545, 123100-123149.5.Google Scholar
California Insurance Code sections 791.01-791.22. California Insurance Information And Privacy Protection Act.Google Scholar
California Penal Code sections 1203.067(b)(3), 3500, 3521-3523.Google Scholar
California Welfare and Institutions Code section 5328-5330. Lanterman, Petris, Short Act confidentiality provisions.Google Scholar
Centers for Disease Control and Prevention (2016), Guideline for Prescribing Opioids for Chronic Pain. www.cdc.gov/drugoverdose/pdf/Guidelines_Factsheet-a.pdf.Google Scholar
Cox v. Miller, 296 F.3d 89 (2d Cir. 2002).Google Scholar
Hason v. Medical Board of California, 279 F.3d 1167 (9th Cir. 2002).Google Scholar
Hedegaard, H., Minino, A. & Warner, M. (2018). Drug Overdose Deaths in the United States, 1999–2017. National Center for Health Statistics Data Brief No. 329, Nov. 2018. www.cdc.gov/nchs/products/databriefs/db329.htm.Google Scholar
In Re: Menna, 11 Cal.4th 975 (1995).Google Scholar
Jaffee v. Redmond, 116 S.Ct. 1923 (1996).Google Scholar
Lewis v. Superior Court, 3 Cal.5th 561 (2017).Google Scholar
Medical Board of California (2010). Guidelines for Prescribing Controlled Substances for Pain.Google Scholar
Medical Board of California (2018). Authorization for Release of Alcohol and Drug Abuse Information.Google Scholar
National Alliance for Model State Drug Laws (2014) Prescription Drug Abuse, Addiction and Diversion, Part 1. www.namsdl.org/library/884CB2C5-1372-636C-DD54DCC00FD31313/.Google Scholar
People v. Ignacio Garcia, 2 Cal.5th 792 (2017).Google Scholar
People v. Gonzales, 56 Cal.4th 353, 371-372 (2013).Google Scholar
Petersen, A., Peters, S. C., Richard, M. H. & Whites, A. (2018). State legislative responses to the opioid crisis: Leading examples. Journal of Health & Life Sciences Law, Feb. 2018, 11, 30.Google Scholar
Powell v. Texas, 392 U.S. 514 (1968).Google Scholar
Robinson v. California, 370 U.S. 660 (1962).Google Scholar
Roe v. Wade, 410 U.S. 113, 93 S.Ct. 705 (1973).Google Scholar
SAMHSA (2017). Substance Abuse Confidentiality Regulations, Frequently Asked Questions (FAQs regarding the Substance Abuse Confidentiality Regulations). September 15, 2017. www.samhsa.gov/about-us/who-we-are/laws-regulations/confidentiality-regulations.htm.Google Scholar
Secretary’s Advisory Committee on Human Research Protection (SACHRP) (2017). Attachment B to December 12, 2017, SACHRP Letter to the HHS Secretary Recommendations on the Interpretation and Application of Exemption §_.104(d)(4), the “HIPAA Exemption”. www.hhs.gov/ohrp/sachrp-committee/recommendations/attachment-b-december-12-2017/index.html.Google Scholar
Seth, P., Scholl, L., Rudd, R. & Bacon, S. (2018). Overdose deaths involving opioids, cocaine, and psychostimulants in United States, 2015–2016. Centers for Disease Control and Prevention, Morbidity, Mortality Weekly Report, March 30, 2018, 67(12), 349–358. www.cdc.gov/mmur/volume/67/wr/mm6712al.htm.Google Scholar
Slater, M. (2018) Note: Is Powell still valid? The Supreme Court’s changing stance on cruel and unusual punishment. Virginia Law Review, 104, 547–588.Google Scholar
SUPPORT ACT (Public Law No. 115-271).Google Scholar
Surgeon General of the United States (1999). Mental Health – A Report of the Surgeon General, Chapter 7, pp. 440–441. https://profiles.nlm.nih.gov/ps/access/NNBBHS.pdf.Google Scholar
Tarasoff v. Regents of the University of California, 17 Cal.3d 425 (1976).Google Scholar
Unger, D. (2014). Student note: Minding your meds: Balancing the needs for patient privacy and law enforcement in prescription drug monitoring programs. West Virginia Law Review, 117, 345–388.Google Scholar
United States Constitution, Fourth Amendment, Eighth Amendment.Google Scholar
U.S. v. Brooks, 628 F.3d 79 (6th Cir. 2011).Google Scholar
U.S. v. Caro, 309 F.3d 1348 (11th Cir. 2002).Google Scholar
U.S. v. Carucci, 33 F.Supp.2d 302 (S.D.N.Y. 1999).Google Scholar
U.S. v. Davis, 182 Fed.Appx. 741 (9th Cir. 2006).Google Scholar
U.S. v. Lighthall, 389 F.3d 791 (8th Cir. 2004).Google Scholar
U.S. v. Liu, 267 F.Supp.2d 371 (E.D.N.Y. 2003).Google Scholar
U.S. v. Miller, 178 Fed.Appx. 70 (2d Cir. 2006).Google Scholar
U.S. v. Long, 185 F.Supp.2d 30 (D.D.C. 2001).Google Scholar
U.S. v. Romualdi, 101 F.3d 971 (3d Cir. 1996).Google Scholar
U.S. v. Sadolsky, 234 F.3d 938 (6th Cir. 2000).Google Scholar
Venezia v. U.S., 884 F.Supp. 919 (D.N.J. 1995) affd. without opin., 77 F.3d 465 (3d Cir. 1995).Google Scholar
Webb v. Smart Document Solutions, LLC, 499 F.3d 1078, 1081 (9th Cir. 2007).Google Scholar
Whalen v. Roe, 429 U.S. 589, 97 S.Ct. 869 (1977).Google Scholar
21 C.F.R. Parts 50 and 56.Google Scholar
21 U.S.C. sections 822-824.Google Scholar
42 C.F.R. Part 2.Google Scholar
42 U.S.C. section 280g-3.Google Scholar
42 U.S.C. section 290dd-2.Google Scholar
42 U.S.C. section 300gg-22.Google Scholar
42 U.S.C. sections 1320d, et seq.Google Scholar
42 U.S.C section 12132.Google Scholar
45 C.F.R. Part 46.Google Scholar
45 C.F.R. Parts 160 and 164.Google Scholar
45 C.F.R. sections 164.508 and 164.512.Google Scholar
82 Federal Register 6053, Confidentiality of Substance Use Disorder Patient Records (2017).Google Scholar